PharmaCompany

Astellas Pharma logo

Astellas Pharma

Most recent

Astellas Pharma utilized Boltz-2 to reduce lab tests by 90% in a drug screening process, successfully narrowing down to 10 active compounds. The leading compound demonstrated performance comparable to an existing benchmark in clinical trials.

1Stories

+1 in the last 30 days

1Deployments tracked

1 live

90%fewer lab tests

Latest tracker entry

MachineCon USA · from AIM Media House

Where enterprise AI is decided

An invitation-led day for the CIOs, CDOs and Chief AI Officers who own enterprise AI strategy.

  • New York5th edition · 583 Park Avenue
  • Dallas1st edition

Register for MachineCon USASee MachineCon USA →

  • Keynote on the main stage, MachineCon New York 2025
  • AI150 award winners on stage, MachineCon New York 2025
  • At the tables, MachineCon New York 2025
  • Networking, MachineCon New York 2025